Amsurg Corp  

(Public, NASDAQ:AMSG)   Watch this stock  
Find more results for Cynthia M. Holden�
55.31
+0.28 (0.51%)
Jan 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 54.79 - 56.99
52 week 40.00 - 56.99
Open 56.00
Vol / Avg. 434,839.00/427,651.00
Mkt cap 2.66B
P/E 44.74
Div/yield     -
EPS 1.24
Shares 48.12M
Beta 1.09
Inst. own 96%
Feb 23, 2015
Q4 2014 Amsurg Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 14, 2015
Amsurg Corp at JPMorgan Healthcare Conference
Dec 2, 2014
Amsurg Corp at Bank of America Merrill Lynch Leveraged Finance Conference - Webcast
Nov 4, 2014
Q3 2014 Amsurg Corp Earnings Call - Webcast
Nov 4, 2014
Q3 2014 Amsurg Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 7.77% 24.00%
Operating margin 18.89% 31.36%
EBITD margin - 33.92%
Return on average assets 4.10% 12.23%
Return on average equity -3.64% 9.96%
Employees 4,100 -
CDP Score - -

Address

SUITE 500, 20 BURTON HILLS BLVD.
NASHVILLE, TN 37215
United States - Map
+1-615-6651283 (Phone)
+1-615-6650755 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (ASCs) in the United States. The Company�s surgery centers are typically located adjacent to or in close proximity to the medical practices of its partner physicians. It generally owns a 51% interest in the facilities that the Company operates. Its surgical facilities primarily provide non-elective, high volume, lower-risk surgical procedures across multiple specialties, including among others gastroenterology, ophthalmology, and orthopedics. As of December 31, 2013, approximately 1.6 million surgical procedures were performed. The Company has over 2,000 preferred specialties of gastroenterology, ophthalmology, orthopedic, ear, nose and throat, or ENT and urology, while the remainder is in specialties such as plastic surgery, podiatry and pain management. The Company believes approximately 50% of its preferred single specialty ASCs and 30% of multi-specialty ASCs are independently owned.

Officers and directors

Steven I. Geringer Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Christopher A. Holden President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Claire M. Gulmi Chief Financial Officer, Executive Vice President, Secretary, Director
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Phillip A. Clendenin President - Ambulatory Services
Age: 49
Bio & Compensation  - Reuters
Robert J. Coward President - Physician Services and Chief Development Officer
Age: 50
Bio & Compensation  - Reuters
Kevin Delon Eastridge Senior Vice President - Finance, Chief Accounting Officer
Age: 48
Bio & Compensation  - Reuters
Shawn G. Strash Senior Vice President - Corporate Services
Age: 51
Bio & Compensation  - Reuters
Thomas G. Cigarran Independent Director
Age: 72
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James A. Deal Independent Director
Age: 64
Bio & Compensation  - Reuters
Henry D. Herr Independent Director
Age: 67
Bio & Compensation  - Reuters